Menkes Disease Latest Advances

Copper in Human Health and Disease: Insights from Inherited Disorders.

Journal: Physiology (Bethesda, Md.)

Published: November 10, 2025

CRISPR prime editing as a promising therapeutic avenue for Menkes disease: the next step in correcting ATP7A mutations.

Journal: Annals of medicine and surgery (2012)

Published: November 04, 2025

Copper Dysregulation and Cardiovascular Disease: A Review of Underlying Mechanisms and Therapeutic Targets.

Journal: Cardiology in review

Published: September 19, 2025

Intravenous AAV9-ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model.

Journal: Science advances

Published: August 29, 2025

Copper homeostasis and cuproptosis: implications for neurodegenerative diseases.

Journal: Frontiers in aging neuroscience

Published: August 19, 2025

Retropseudogene insertion generated through retrotransposition in the ATP7A gene results in premature stop codons and a case of Menkes disease.

Journal: Frontiers in neurology

Published: August 07, 2025

Elesclomol-copper therapy improves neurodevelopment in two children with Menkes disease.

Journal: The Journal of clinical investigation

Published: July 29, 2025

Early-onset urinary calculi in Menkes disease: A rare presentation in a 5-month-old infant.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: June 11, 2025

Interference-free SERS tags for copper ion sensing upon hypoxia by in situ hot-spot generation.

Journal: Talanta

Published: May 14, 2025

Alpha-synuclein null mutation exacerbates the phenotype of a model of Menkes disease in female mice.

Journal: Frontiers in neuroscience

Published: April 16, 2025

Research Progress in Copper Homeostasis and Diseases.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae